Not sure if this was mentioned here or not, hard to weed through all the babble posted here lately.. I will say one thing, and maybe I'm just a cold fish (no offense fishdoc), when I finish up my 72 weeks, you won't see my ass here making multiple postings on a daily basis....Take back your life and move on already!!! ( I know, here to support others etc., etc., yada, yada....I still suspect forum addiction for many)
Kudos to JmJm, maybe he has decided to start living again out in the "real world".. Everytime I think of jim and his scooter, I have visions of peewee herman on his bike
FDA Grants Fast Track Status for HCV-796 for Treatment of Hepatitis C Virus Infection
EXTON, Pa., June 27, 2007 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation for HCV-796 for treatment of hepatitis C virus infection. HCV-796, a unique orally dosed non nucleoside hepatitis C viral polymerase inhibitor that interferes with the replication of hepatitis C virus (HCV), is currently undergoing Phase 2 evaluation and is being co-developed with Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE).
Under the FDA Modernization Act of 1997, fast track designation may potentially expedite the review of a drug that is intended for the treatment of a serious life-threatening condition and demonstrates the potential to address an unmet medical need for such a condition. Fast track designation allows the FDA to accept, on a rolling basis, portions of a marketing application for review prior to the completion of the final registration package. However, the designation does not guarantee approval or expedited approval of any application for the product.
"The receipt of fast track designation for HCV-796 is an important regulatory step forward as we continue to work closely with the FDA and our Wyeth colleagues throughout the development process," commented Robert Pietrusko, Pharm.D, ViroPharma's vice president of global regulatory affairs and quality.